Read the latest insights from #GU26

From genomic predictors to real‑world combination strategies, experts highlight TP53 status as a potential marker of benefit, broad activity across disease features, and evolving mCRPC approaches

ow.ly/tuHe50Ypb0U

#ASCOGU #ASCOGU2026 #MedEd #MedSky

📹 Joaquim Bellmunt, MD, PhD, of @danafarber.bsky.social discusses the mechanism of action of FX909 in patients with locally-advanced or metastatic urothelial cancer during the 2026 Genitourinary Cancers Symposium. @ascocancer.bsky.social #GU26 #oncology #ASCOGU2026

Day 3 of @ASCO #GU26 is in full swing! Stay tuned to onclive.com for all of our coverage of today's presentations. #oncology #ASCOGU2026

We are back on site at the Moscone West in San Francisco for the final day of @ascocancer.bsky.social #GU26 Stop by room 2004 if you are interested in participating in an interview and check out hubs.li/Q0454Jtf0 for our full coverage! #oncology #kcsm #RCC #ASCOGU2026

Gracias a su tecnología de "doble enmascaramiento", logra una gran eficacia con efectos secundarios mínimos. #InvestigacionMedica #Ciencia #ASCOGU2026 #SaludMasculina

🎥 This year at @ascocancer.bsky.social #GU26, we asked our interviewees which abstracts they were most looking forward to seeing at the meeting and their must-have food or drink for a conference!
#oncology #RCC #kcsm #GUcancer #ASCOGU2026
Hear what they had to say below:

We were happy to have Enrique Gallardo, MD, join us for an interview to discuss data from the PEACE-3 trial that were presented here at @ascocancer.bsky.social #GU26 Check out clips from our interview on onclive.com now! #oncology #ASCOGU2026

Thanks to Thomas Powles, MD, MBBS, MRCP, who stopped by for an interview to discuss the IMvigor011 trial! Check back on onclive.com for highlights from the interview #oncology #ASCOGU2026

Our next interview was with Mohammad Arfat Ganiyani, MBBS, of Miami Cancer Institiute! We discussed his study on lutetium lu 177 in mCRPC. Stay tuned to onclive.com for all of our coverage ahead of #ASCOGU2026 #oncology

Thank you to Nadine Mahmoud, MD, for stopping by for an interview during the Fellows Forum to discuss her group's presentation on the prognostic role of PD-L1 in penile squamous cell carcinoma. Visit onclive.com for highlights from the interview #oncology #ASCOGU2026

The presentations are in full swing at our National Fellows Forum ahead of #ASCOGU2026. Stay tuned to onclive.com for all of our coverage! #oncology #GUcancer

Ahead of #ASCOGU2026 we are live in San Francisco for our National Fellows Forum: Genitourinary Cancer! Stay tuned to onclive.com for our coverage of exciting research by fellows from across the country. #oncology #GUcancer

We will be on-site in San Francisco for the @ascocancer.bsky.social Genitourinary Cancers Symposium later this week from 2/26 through 2/28! Reach out to kdoherty@mjhlifesciences.com if you are interested in connecting for an interview. #oncology #ASCOGU2026

OncLive will be on-site at the 2026 ASCO Genitourinary Cancers Symposium! Reach out to kdoherty@mjhlifesciences.com if you are interested in scheduling an interview. #oncology #ASCOGU2026